alexa Inflammatory Bowel Diseases and their Associated Risks | Open Access Journals
ISSN: 2476-1958
Journal of Inflammatory Bowel Diseases & Disorders
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Inflammatory Bowel Diseases and their Associated Risks

Arnon Blum*

Department of Medicine, Bar Ilan University, Israel

*Corresponding Author:
Arnon Blum
Department of Medicine
Bar Ilan University, Israel
Tel: 972547503041
E-mail: A [email protected]

Received date: November 08, 2016; Accepted date: November 08, 2016; Published date: November 15, 2016

Citation: Blum A (2016) Inflammatory Bowel Diseases and their Associated Risks. J Inflam Bowel Dis Disor 2:e103.

Copyright: © 2016 Blum A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Inflammatory Bowel Diseases & Disorders

Editor Note

Journal of inflammatory bowel diseases disorders volume1 issue 1 had published research articles of current research interest contributed from across the world.

Many epidemiological studies have searched for the elements that may shed light on the etiology of IBD, particularly in pediatric siblings. Researcher aims to study about the pediatric siblings Inflammatory Bowel Disease (IBD).The findings state that antibiotic exposure or other environmental factor may be responsible for the present cause [1].

Present study investigated the correlation of infliximab (IFX) trough concentration to the clinical remission (CM) and mucosal healing (MH). Results depict that study found a significant association between IFX trough level with CR and MH. The study concludes that therapeutic drug monitoring is an important diagnostic tool for IBD patients and should routinely be implemented to optimize the outcome of the treatment [2].

Mention about the author purpose of present investigation is to examine the role of miRNAs in regulating DEFA5 expression using Caco-2 cells as a model of Paneth cells, which could further implicate both IBD pathogenesis. Investigation founds that miR-124 and miR-924 negatively regulate DEFA5 mRNA and protein expression [3].

Study on inflammatory bowel diseases had vital and wide applications and aims to identify the educational needs and barriers along with the factors associated with non-adherence among inflammatory bowel disease (IBD) patients. The study identified the factors associated with IBD patients and the findings can be used to develop educational resources to improve the adherence among IBD patients [4].

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 1502
  • [From(publication date):
    January-2017 - Jun 22, 2017]
  • Breakdown by view type
  • HTML page views : 1464
  • PDF downloads :38
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords